https://www.selleckchem.com/pr....oducts/iberdomide.ht
The patient scores were calculated and divided into high- and low-risk groups. The model could effectively predict the prognosis in patients of different stages. The AUC of the model is 0.784, which was significantly higher than that of the other variables. There were significant differences in the distribution of immune-related genes between two groups; the immune score and immune function enrichment score were higher in the low risk group. The aim of this study was to investigate the role of the tumor necrosis factor and HNRNPL rel
Curtir
Comentario
Compartilhar
